Procavea
Zürich, CH · 2 known investors
Find your way into Procavea
Sign up to see every warm intro you have to Procavea
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Procavea team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Procavea Biotech develops a protein-based molecular delivery platform (nonviral protein cages) to address delivery limitations in RNA therapeutics, with applications also in medical imaging. An ETH Zurich spin-off, it targets the pharmaceutical and biotech sector.
Founders & leadership
TE

Tom EdwardsonTom Edwardson is a researcher with expertise in protein engineering and designed protein cages for molecular delivery. His published work includes research on RNA packaging in protein cages and DNA nanotechnology, with publications in Nature Chemistry and the Journal of the American Chemical Society.
Investors · 2
Kickfund✓ confirmed by ProcaveaBasel · $950K
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
Venture KickreportedSchlieren-Zürich
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Procavea do?
- Procavea Biotech develops a protein-based molecular delivery platform (nonviral protein cages) to address delivery limitations in RNA therapeutics, with applications also in medical imaging. An ETH Zurich spin-off, it targets the pharmaceutical and biotech sector.
- Who founded Procavea?
- Procavea was founded by Tom Edwardson.
- Who are Procavea's investors?
- Procavea's investors include Kickfund, Venture Kick.
- Where is Procavea headquartered?
- Procavea is headquartered in Zürich, CH.

